XASE · Healthcare · Medical Devices
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. Tghe company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.
Electromed delivered a solid quarter, with **$0.39 EPS** beating by **$0.07** despite **$19M revenue** missing estimates. Growth remains strong for this medical-device niche, but the top-line miss and only modest **$3M** operating income make this a decent, not great, print.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | Q4 2026 | 0.32 | 0.39 | +21.88% | $19.4M | ✅ Beat | -3.21% | -31.11% | — |
| 2026-05-12 | Q3 2026 | 0.25 | 0.35 | +40.00% | $18.6M | ✅ Beat | +5.22% | +41.07% | +38.27% |
| 2026-02-10 |
| Q2 2026 |
| 0.26 |
| 0.32 |
| +23.08% |
| $18.9M |
| ✅ Beat |
| +2.99% |
| -9.69% |
| -17.07% |
| 2025-11-12 | Q1 2026 | 0.21 | 0.25 | +19.05% | $16.9M | ✅ Beat | — | — | — |
| 2025-08-26 | Q4 2025 | 0.22 | 0.25 | +13.64% | $17.4M | ✅ Beat | +12.63% | +15.92% | +12.49% |
| 2025-02-11 | Q2 2025 | 0.00 | 0.22 | +100.00% | $16.3M | ✅ Beat | +13.97% | +1.20% | -15.75% |
| 2024-11-12 | Q1 2025 | 0.03 | 0.16 | +433.33% | $14.7M | ✅ Beat | +5.11% | +5.60% | +8.17% |
| 2024-08-27 | Q4 2024 | 0.14 | 0.20 | +42.86% | $14.8M | ✅ Beat | -6.54% | +7.48% | +21.62% |
Showing last 8 quarters.